Clinical Trials Directory

Trials / Completed

CompletedNCT06735235

Salivary Fluoride Clearance

Evaluation of Salivary Fluoride Clearance Following the Use of Three MFP-Containing Dentifrices

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Procter and Gamble · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a single-center, four-treatment, four-period crossover study. Over the course of the study, up to thirty qualified subjects will use four (4) study treatment products, one time each according to the randomization. Subjects will brush with 1.25g of the assigned study product at each visit. Subjects will provide saliva samples at baseline and at 2, 6, 12, and 30 minutes post-treatment. The F- concentrations in each saliva sample will be determined by ion chromatography

Conditions

Interventions

TypeNameDescription
DRUG0 ppm FEach subject will be randomly assigned to this treatment during one of the four periods for this crossover study.
DRUG250 ppm F as MFPEach subject will be randomly assigned to this treatment during one of the four periods for this crossover study.
DRUG1100 ppm as MFPEach subject will be randomly assigned to this treatment during one of the four periods for this crossover study.
DRUG2800 ppm F as MFPEach subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

Timeline

Start date
2021-07-14
Primary completion
2021-07-29
Completion
2021-07-29
First posted
2024-12-16
Last updated
2024-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06735235. Inclusion in this directory is not an endorsement.